Skip to main content

ADVERTISEMENT

high bleeding risk

Optimal Stent Design for High Bleeding Risk Patients: Evidence From a Network Meta-Analysis
03/01/2021

Juan G. Chiabrando, MD1,2,3;  Giovanni M. Vescovo, MD4
Marco Giuseppe Del Buono, MD5;  Marco Lombardi, MD5
Massimiliano Camilli, MD5;  Krishna Ravindra, MD1;
Rocco Antonio Montone, MD5,6;  Giampaolo Niccoli, MD5,6;
Giuseppe Biondi-Zoccai, MD, MStat7,8

Juan G. Chiabrando, MD1,2,3;  Giovann...
Polymer-free (PF) drug-eluting stent (DES) devices have a proven benefit over bare-metal stent (BMS) devices in previous trials. It is unknown, however, whether polymer-based (PB)-DES devices are as safe as PF-DES devices.
Polymer-free (PF) drug-eluting stent (DES) devices have a proven benefit over bare-metal stent (BMS) devices in previous trials. It is unknown, however, whether polymer-based (PB)-DES devices are as safe as PF-DES devices.
Polymer-free (PF) drug-eluting...
03/01/2021
Journal of Invasive Cardiology